Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
1.470
-0.060 (-3.92%)
Apr 29, 2026, 2:00 PM EDT - Market open
Estrella Immunopharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2024 | FY 2023 | FY 2022 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| Net Income | -13.06 | -8.85 | -7.31 | -11.11 | -1.69 | |
| Stock-Based Compensation | 0.62 | 0.43 | 1.19 | 0.41 | 0.13 | |
| Other Operating Activities | 0.04 | - | - | - | - | |
| Change in Accounts Payable | 0.55 | -0.07 | -9.33 | 8.39 | - | |
| Change in Income Taxes | -0 | -0.04 | - | - | - | |
| Change in Other Net Operating Assets | 10.07 | 0.89 | -0.62 | 0.98 | 0.11 | |
| Operating Cash Flow | -1.79 | -7.64 | -16.07 | -1.34 | -1.44 | |
| Other Investing Activities | - | - | 4.96 | -0.27 | - | |
| Investing Cash Flow | - | - | 4.96 | -0.27 | - | |
| Short-Term Debt Issued | - | - | 0.3 | - | - | |
| Total Debt Issued | - | - | 0.3 | - | - | |
| Short-Term Debt Repaid | - | - | -0.3 | - | - | |
| Total Debt Repaid | - | - | -0.3 | - | - | |
| Issuance of Common Stock | 2.4 | 0.08 | 10 | - | 0.02 | |
| Repurchase of Common Stock | -0.03 | -0.57 | -5.43 | - | - | |
| Other Financing Activities | -0.12 | - | -0.8 | - | 0.52 | |
| Financing Cash Flow | 2.25 | -0.49 | 12.79 | - | 5.53 | |
| Net Cash Flow | 0.47 | -8.13 | 1.69 | -1.61 | 4.09 | |
| Cash Interest Paid | - | - | 0 | - | - | |
| Cash Income Tax Paid | 0 | 0.04 | 0 | - | - | |
| Levered Free Cash Flow | 3.43 | - | -12.95 | 2.81 | - | |
| Unlevered Free Cash Flow | 3.43 | - | -12.95 | 2.81 | - | |
| Change in Working Capital | 10.62 | 0.78 | -9.95 | 9.37 | 0.11 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.